Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine.

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine. Vaccine. 1996 Oct; 14(14):1366-74.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.